🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to better understand the influence of insuli...
Status
Completed
Location
Multiple Locations
Start Date
2002-04
Trial ID
NCT00351871
Treatments Being Tested
Patients receiving a patient assistance program during therapy for Hepatiti...
Status
Completed
Location
Multiple Locations
Start Date
2005-03
Trial ID
NCT00704522
Treatments Being Tested
This phase 2b study will evaluate the efficacy and safety of 16 and 24 week...
Status
Completed
Location
Mayo Clinic
Start Date
2010-10
Trial ID
NCT01225380
Analysis of HCV-specific T cell responses in patients treated with boceprev...
Status
Completed
Location
Unit of Infectious Diseases and Hepatology
Start Date
2012-04
Trial ID
NCT01403181
Treatments Being Tested
This study is a multi-center, randomized, open-label and positive controlle...
Status
Completed
Location
302 Military Hospital
Start Date
2010-07
Trial ID
NCT01140997
Treatments Being Tested
The current gold standard for treatment of chronic hepatitis C (CHC) patien...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00727259
Treatments Being Tested
The purpose of this study is to determine whether BMS-790052 added to Pegin...
Status
Completed
Location
Alabama Liver & Digestive Specialists (Alds)
Start Date
2010-08
Trial ID
NCT01170962
Treatments Being Tested
The purpose of this study is to evaluate the impact of a physician directed...
Status
Completed
Location
California Liver Institute
Start Date
2011-12
Trial ID
NCT01405027
Treatments Being Tested
This is a Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Eval...
Status
Completed
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01356160
Treatments Being Tested
1. To characterize the tolerability profile of subcutaneous (SC) CPG 10101 ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-09
Trial ID
NCT00142103